{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:32:45Z","timestamp":1786523565797,"version":"build-2736575974"},"reference-count":224,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shenzhen Qingke Shanbao Biomedical Development Co., Ltd. New Drug Research and Development Project","award":["20249660017"],"award-info":[{"award-number":["20249660017"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2023YFA0914300"],"award-info":[{"award-number":["2023YFA0914300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2023YFA0915700"],"award-info":[{"award-number":["2023YFA0915700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Science and Technology Program","award":["KCXFZ20230731093402005"],"award-info":[{"award-number":["KCXFZ20230731093402005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Paclitaxel (PTX) is a core first-line chemotherapeutic agent used to treat a broad spectrum of cancers, which remain leading causes of death worldwide. However, the emergence of intrinsic and acquired resistance critically contributes to chemotherapy failure, thereby promoting tumor recurrence and metastasis and resulting in a poor prognosis. PTX resistance is a complex biological process driven by multiple factors and cross-regulated signaling pathways. It encompasses a wide variety of mechanisms, including aberrations in microtubules and related proteins; changes in mitotic systems and chromosomal instability (CIN); epigenetic modifications including ncRNA regulation, DNA methylation, and histone modification; enhanced drug efflux and dysregulation of proliferation and apoptotic signaling pathways; enhanced protective autophagy; metabolic reprogramming; cell plasticity (increased EMT and cancer cell stemness); TME remodeling; and immune regulation. This review systematically examines the core molecular mechanisms of PTX resistance, summarizes cutting-edge strategies to reverse chemoresistance and their clinical translation, and discusses current challenges and future directions, thereby providing a theoretical framework for optimizing PTX-based regimens and overcoming clinical resistance.<\/jats:p>","DOI":"10.3390\/ijms27167187","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T13:46:16Z","timestamp":1786455976000},"page":"7187","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms of Paclitaxel Resistance: Recent Advances and Future Perspectives"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2152-3440","authenticated-orcid":false,"given":"Jialong","family":"Xie","sequence":"first","affiliation":[{"name":"College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518055, China"},{"name":"Department of Biopharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology, Shenzhen 518107, China"},{"name":"Center for Cancer Immunotherapy, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxuan","family":"Ren","sequence":"additional","affiliation":[{"name":"Shenzhen Key Laboratory of Health Science and Technology, Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China"},{"name":"Open FIESTA (Faculty for Innovation, Education, Science, Technology and Art) Center, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China"},{"name":"State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9406-6913","authenticated-orcid":false,"given":"Zhibin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology, Shenzhen 518107, China"},{"name":"Center for Cancer Immunotherapy, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5561-7663","authenticated-orcid":false,"given":"Weidong","family":"Xie","sequence":"additional","affiliation":[{"name":"Shenzhen Key Laboratory of Health Science and Technology, Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China"},{"name":"Open FIESTA (Faculty for Innovation, Education, Science, Technology and Art) Center, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China"},{"name":"State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and Limitations in Traditional Anti-Cancer Therapies: A Comprehensive Review of Surgery, Chemotherapy, Radiation Therapy, and Hormonal Therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung Cancer Immunotherapy: Progress, Pitfalls, and Promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast Cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer Treatment Therapies: Traditional to Modern Approaches to Combat Cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","article-title":"Antibody-Drug Conjugates Come of Age in Oncology","volume":"22","author":"Dumontet","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","article-title":"Protein Degraders Enter the Clinic\u2014A New Approach to Cancer Therapy","volume":"20","author":"Chirnomas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T Cell Immunotherapy for Human Cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 Signalling Axis in Cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced Targeted Therapies in Cancer: Drug Nanocarriers, the Future of Chemotherapy","volume":"93","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lim, P.T., Goh, B.H., and Lee, W.L. (2022). Taxol: Mechanisms of Action against Cancer, an Update with Current Research. Paclitaxel, Academic Press.","DOI":"10.1016\/B978-0-323-90951-8.00007-2"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12935-024-03415-0","article-title":"Key Genes and Molecular Mechanisms Related to Paclitaxel Resistance","volume":"24","author":"Alalawy","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2022.10.006","article-title":"Mechanisms of Cancer Metastasis","volume":"87","author":"Castaneda","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/17425255.2021.1943358","article-title":"Current Opinion on the Pharmacogenomics of Paclitaxel-Induced Toxicity","volume":"17","author":"AlAhmad","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gallego-Jara, J., Lozano-Terol, G., Sola-Mart\u00ednez, R.A., C\u00e1novas-D\u00edaz, M., and Puente, T.d.D. (2020). A Compressive Review about Taxol\u00ae: History and Future Challenges. Molecules, 25.","DOI":"10.3390\/molecules25245986"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10495-022-01750-z","article-title":"Mechanisms of Cancer Cell Death Induction by Paclitaxel: An Updated Review","volume":"27","author":"Zhao","year":"2022","journal-title":"Apoptosis"},{"key":"ref_18","first-page":"100918","article-title":"Paclitaxel Resistance in Breast Cancer: Current Challenges and Recent Advanced Therapeutic Strategies","volume":"43","author":"Abouzeid","year":"2025","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/bcr2573","article-title":"Chemotherapy Resistance in Metastatic Breast Cancer: The Evolving Role of Ixabepilone","volume":"12","author":"Rivera","year":"2010","journal-title":"Breast Cancer Res. BCR"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and Resistance to Tubulin-Binding Agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1568011053352569","article-title":"Targeting Microtubules for Cancer Chemotherapy","volume":"5","author":"Zhou","year":"2005","journal-title":"Curr. Med. Chem.-Anti-Cancer Agents"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40001-024-01657-2","article-title":"Paclitaxel and Its Semi-Synthetic Derivatives: Comprehensive Insights into Chemical Structure, Mechanisms of Action, and Anticancer Properties","volume":"29","author":"Sati","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11658-019-0164-y","article-title":"Progress in Research on Paclitaxel and Tumor Immunotherapy","volume":"24","author":"Zhu","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrm3494","article-title":"Microtubule Attachment and Spindle Assembly Checkpoint Signalling at the Kinetochore","volume":"14","author":"Foley","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nmat3858","article-title":"Transformation of Taxol-Stabilized Microtubules into Inverted Tubulin Tubules Triggered by a Tubulin Conformation Switch","volume":"13","author":"Needleman","year":"2014","journal-title":"Nat. Mater."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Nawara, H.M., Afify, S.M., Hassan, G., Zahra, M.H., Seno, A., and Seno, M. (2021). Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy. Biomedicines, 9.","DOI":"10.3390\/biomedicines9050500"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1124\/mol.64.1.51","article-title":"Bcl-2 down-Regulation Is a Novel Mechanism of Paclitaxel Resistance","volume":"64","author":"Ferlini","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_28","first-page":"5349","article-title":"Paclitaxel Induces Release of Cytochrome c from Mitochondria Isolated from Human Neuroblastoma Cells\u2019","volume":"60","author":"Braguer","year":"2000","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/sj.onc.1206280","article-title":"Paclitaxel-Induced Apoptosis in BJAB Cells Proceeds via a Death Receptor-Independent, Caspases-3\/-8-Driven Mitochondrial Amplification Loop","volume":"22","author":"Wieder","year":"2003","journal-title":"Oncogene"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1186\/s12884-024-06897-y","article-title":"The Mechanism of Paclitaxel Induced Damage on Placental Trophoblast Cells","volume":"24","author":"Yu","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13273-020-00093-7","article-title":"Paclitaxel Inhibits Proliferation and Promotes Apoptosis through Regulation ROS and Endoplasmic Reticulum Stress in Osteosarcoma Cell","volume":"16","author":"Li","year":"2020","journal-title":"Mol. Cell. Toxicol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e2955","DOI":"10.1038\/cddis.2017.346","article-title":"WWOX Sensitises Ovarian Cancer Cells to Paclitaxel via Modulation of the ER Stress Response","volume":"8","author":"Janczar","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.21873\/cgp.20288","article-title":"The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-Resistant Non-Small Cell Lung Cancer Cells","volume":"18","author":"Mohiuddin","year":"2021","journal-title":"Cancer Genom. Proteom."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Liebl, M.C., and Hofmann, T.G. (2021). The Role of P53 Signaling in Colorectal Cancer. Cancers, 13.","DOI":"10.3390\/cancers13092125"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.7150\/ijms.61944","article-title":"P53-Dependent Apoptosis Is Essential for the Antitumor Effect of Paclitaxel Response to DNA Damage in Papillary Thyroid Carcinoma","volume":"18","author":"Wu","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbrc.2014.02.053","article-title":"P53 Down-Regulates SETDB1 Gene Expression during Paclitaxel Induced-Cell Death","volume":"446","author":"Noh","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbrc.2018.08.142","article-title":"Paclitaxel Promotes Lung Cancer Cell Apoptosis via MEG3-P53 Pathway Activation","volume":"504","author":"Xu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/2211-5463.12855","article-title":"PBK Attenuates Paclitaxel-Induced Autophagic Cell Death by Suppressing P53 in H460 Non-Small-Cell Lung Cancer Cells","volume":"10","author":"Park","year":"2020","journal-title":"FEBS Open Bio"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"106094","DOI":"10.1016\/j.biocel.2021.106094","article-title":"Cancer: The Role of Iron and Ferroptosis","volume":"141","author":"Rishi","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An Iron-Dependent Form of Non-Apoptotic Cell Death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1166\/jbn.2024.3864","article-title":"Paclitaxel Inhibits Thyroid Cancer by Regulating AMPK\/mTOR and Promoting Ferroptosis","volume":"20","author":"Li","year":"2024","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_42","unstructured":"Qiu, Y., Yu, Q., Ji, M., Zhang, Z., Kang, L., Fu, Y., and Feng, M. (2026, May 09). Activation Ferroptosis Enhanced the Therapy Sensitivity of TNBC to Paclitaxel via NCOA4 Mediated Ferritinophagy. Available online: https:\/\/assets-eu.researchsquare.com\/files\/rs-360631\/v1\/fea159f9-028a-4b34-830a-c969e70e7f00.pdf?c=1631880687."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s10495-019-01515-1","article-title":"Chemotherapeutic Paclitaxel and Cisplatin Differentially Induce Pyroptosis in A549 Lung Cancer Cells via Caspase-3\/GSDME Activation","volume":"24","author":"Zhang","year":"2019","journal-title":"Apoptosis Int. J. Program. Cell Death"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10565-020-09514-8","article-title":"The Role of Caspase-1\/GSDMD-Mediated Pyroptosis in Taxol-Induced Cell Death and a Taxol-Resistant Phenotype in Nasopharyngeal Carcinoma Regulated by Autophagy","volume":"36","author":"Wang","year":"2020","journal-title":"Cell Biol. Toxicol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Gong, W., Fang, P., Leng, M., and Shi, Y. (2023). Promoting GSDME Expression through DNA Demethylation to Increase Chemosensitivity of Breast Cancer MCF-7\/Taxol Cells. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0282244"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ajco.13449","article-title":"Role and Mechanism of Autophagy-Regulating Factors in Tumorigenesis and Drug Resistance","volume":"17","author":"Usman","year":"2021","journal-title":"Asia-Pac. J. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11010-010-0638-8","article-title":"Crosstalk between Autophagy and Apoptosis in the Regulation of Paclitaxel-Induced Cell Death in v-Ha-Ras-Transformed Fibroblasts","volume":"348","author":"Eum","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"ref_48","first-page":"4281","article-title":"Combination of Pristimerin and Paclitaxel Additively Induces Autophagy in Human Breast Cancer Cells via ERK1\/2 Regulation","volume":"18","author":"Lee","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/01913123.2017.1334019","article-title":"Paclitaxel Induces Autophagy in Gastric Cancer BGC823 Cells","volume":"41","author":"Yu","year":"2017","journal-title":"Ultrastruct. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Xie, Q., Chen, Y., Tan, H., Liu, B., Zheng, L.-L., and Mu, Y. (2021). Targeting Autophagy with Natural Compounds in Cancer: A Renewed Perspective from Molecular Mechanisms to Targeted Therapy. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.748149"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2011.03.026","article-title":"Autophagy Inhibition Promotes Paclitaxel-Induced Apoptosis in Cancer Cells","volume":"307","author":"Xi","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"23490","DOI":"10.1038\/s41598-021-02503-9","article-title":"The Effect of Paclitaxel on Apoptosis, Autophagy and Mitotic Catastrophe in AGS Cells","volume":"11","author":"Khing","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_53","first-page":"283","article-title":"Paclitaxel and Immune System","volume":"38","author":"Javeed","year":"2009","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00262-008-0586-2","article-title":"Paclitaxel Reduces Regulatory T Cell Numbers and Inhibitory Function and Enhances the Anti-Tumor Effects of the TLR9 Agonist PF-3512676 in the Mouse","volume":"58","author":"Vicari","year":"2009","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/0008-5472.CAN-17-3480","article-title":"Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner","volume":"78","author":"Wanderley","year":"2018","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12967-015-0567-0","article-title":"Improved Natural Killer Cell Activity and Retained Anti-Tumor CD8+ T Cell Responses Contribute to the Induction of a Pathological Complete Response in HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy","volume":"13","author":"Muraro","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1158\/0008-5472.CAN-14-0067","article-title":"Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner","volume":"74","author":"Hall","year":"2014","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1158\/1078-0432.CCR-18-1038","article-title":"Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration","volume":"24","author":"Oweida","year":"2018","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1038\/sj.onc.1206934","article-title":"Mechanisms of Taxol Resistance Related to Microtubules","volume":"22","author":"Orr","year":"2003","journal-title":"Oncogene"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1172\/JCI119642","article-title":"Taxol-Resistant Epithelial Ovarian Tumors Are Associated with Altered Expression of Specific Beta-Tubulin Isotypes","volume":"100","author":"Kavallaris","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1038\/srep09529","article-title":"Alterations in Ovarian Cancer Cell Adhesion Drive Taxol Resistance by Increasing Microtubule Dynamics in a FAK-Dependent Manner","volume":"5","author":"McGrail","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41392-020-00396-0","article-title":"Aberrantly High Activation of a FoxM1\u2013STMN1 Axis Contributes to Progression and Tumorigenesis in FoxM1-Driven Cancers","volume":"6","author":"Liu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2174\/138920111795163931","article-title":"Advances in the Molecular Detection of ABC Transporters Involved in Multidrug Resistance in Cancer","volume":"12","author":"Gillet","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-60761-416-6_4","article-title":"Mechanisms of Multidrug Resistance in Cancer","volume":"596","author":"Gillet","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Stasiak, P., Sopel, J., Lipowicz, J.M., Raw\u0142uszko-Wieczorek, A.A., Sterzy\u0144ska, K., Korbecki, J., and Januchowski, R. (2025). Elacridar Reverses P-Gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262412105"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e70394","DOI":"10.1002\/jbt.70394","article-title":"Apigenin Modulates Expression Pattern of Cancer Multidrug Resistance Proteins in Non-Small Lung Cancer Cell Line","volume":"39","author":"Padder","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2492238","DOI":"10.1080\/19420862.2025.2492238","article-title":"Successful Targeting of Multidrug-Resistant Tumors with Bispecific Antibodies","volume":"17","author":"Briante","year":"2025","journal-title":"mAbs"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Ye, Z., Hong, C., Jiang, M., Zou, W., Ren, Y., Li, M., Xue, X., Xie, X., Zhang, T., and Ding, Y. (2025). Polyphyllin H Reverses Paclitaxel Resistance in Breast Cancer by Binding Membrane Cholesterol to Inhibit Both ABCB1 and ABCC3. Pharmaceuticals, 18.","DOI":"10.3390\/ph18111699"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/cas.15448","article-title":"H1.0 Induces Paclitaxel-Resistance Genes Expression in Ovarian Cancer Cells by Recruiting GCN5 and Androgen Receptor","volume":"113","author":"Kohli","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"360","DOI":"10.33594\/000000663","article-title":"Activity of Lysosomal ABCC3, ABCC5 and ABCC10 Is Responsible for Lysosomal Sequestration of Doxorubicin and Paclitaxel-Oregongreen488 in Paclitaxel-Resistant Cancer Cell Lines","volume":"57","author":"Gronkowska","year":"2023","journal-title":"Cell Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"201049","DOI":"10.1016\/j.omton.2025.201049","article-title":"HIF1A, BRG1, and P300 Interaction Confers Paclitaxel-Induced Drug Resistance by Enabling the Overexpression of ABCC Genes","volume":"33","author":"Gronkowska","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.7150\/ijbs.104483","article-title":"MNX1-AS1 Suppresses Chemosensitivity by Activating the PI3K\/AKT Pathway in Breast Cancer","volume":"21","author":"Shuai","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Liu, M., Xu, C., Qin, X., Liu, W., Li, D., Jia, H., Gao, X., Wu, Y., Wu, Q., and Xu, X. (2022). DHW-221, a Dual PI3K\/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-Gp\/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-Small Cell Lung Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.873649"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in Cancer: Mechanisms and Advances in Clinical Trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.18632\/aging.203241","article-title":"CXCR4 Knockdown Enhances Sensitivity of Paclitaxel via the PI3K\/Akt\/mTOR Pathway in Ovarian Carcinoma","volume":"14","author":"Zi","year":"2022","journal-title":"Aging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.2147\/OTT.S161198","article-title":"Effects of Proton Pump Inhibitors on Reversing Multidrug Resistance via Downregulating V-ATPases\/PI3K\/Akt\/mTOR\/HIF-1\u03b1 Signaling Pathway through TSC1\/2 Complex and Rheb in Human Gastric Adenocarcinoma Cells in Vitro and in Vivo","volume":"11","author":"Chen","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Sui, M., Yang, H., Guo, M., Li, W., Gong, Z., Jiang, J., and Li, P. (2021). Cajanol Sensitizes A2780\/Taxol Cells to Paclitaxel by Inhibiting the PI3K\/Akt\/NF-\u03baB Signaling Pathway. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.783317"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41419-026-08501-x","article-title":"ROR1-PI3K\/AKT Signaling Drives Adaptive Resistance to Cell Cycle Blockade in TP53 Mutated Ovarian Cancer","volume":"17","author":"Raivola","year":"2026","journal-title":"Cell Death Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ccell.2023.04.017","article-title":"Evolutionary States and Trajectories Characterized by Distinct Pathways Stratify Patients with Ovarian High Grade Serous Carcinoma","volume":"41","author":"Lahtinen","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41589-024-01761-8","article-title":"A Multiplex Single-Cell RNA-Seq Pharmacotranscriptomics Pipeline for Drug Discovery","volume":"21","author":"Dini","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s12031-021-01832-8","article-title":"Tenascin C Promotes Glioma Cell Malignant Behavior and Inhibits Chemosensitivity to Paclitaxel via Activation of the PI3K\/AKT Signaling Pathway","volume":"71","author":"Zhang","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12094-017-1724-0","article-title":"Inhibiting ERK\/Mnk\/eIF4E Broadly Sensitizes Ovarian Cancer Response to Chemotherapy","volume":"20","author":"Liu","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1038\/s41388-022-02329-3","article-title":"Role of P38 MAP Kinase in Cancer Stem Cells and Metastasis","volume":"41","author":"Kudaravalli","year":"2022","journal-title":"Oncogene"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Lim\u00f3n, A., Joaquin, M., Caballero, M., Posas, F., and de Nadal, E. (2020). The P38 Pathway: From Biology to Cancer Therapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061913"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Salaroglio, I.C., Mungo, E., Gazzano, E., Kopecka, J., and Riganti, C. (2019). ERK Is a Pivotal Player of Chemo-Immune-Resistance in Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102505"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"114355","DOI":"10.1016\/j.yexcr.2024.114355","article-title":"Ganoderma Lucidum Extract Reverses Multidrug Resistance in Breast Cancer Cells through Inhibiting ATPase Activity of the P-Glycoprotein via MAPK\/ERK Signaling Pathway","volume":"444","author":"Jiao","year":"2025","journal-title":"Exp. Cell Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.etap.2011.12.006","article-title":"Gambogenic Acid Induced Mitochondrial-Dependent Apoptosis and Referred to Phospho-Erk1\/2 and Phospho-P38 MAPK in Human Hepatoma HepG2 Cells","volume":"33","author":"Yan","year":"2012","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1159\/000524305","article-title":"Cobimetinib Sensitizes Cervical Cancer to Paclitaxel via Suppressing Paclitaxel-Induced ERK Activation","volume":"107","author":"Liu","year":"2022","journal-title":"Pharmacology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"113733","DOI":"10.1016\/j.bcp.2019.113733","article-title":"Overcoming Taxol-Resistance in A549 Cells: A Comprehensive Strategy of Targeting P-Gp Transporter, AKT\/ERK Pathways, and Cytochrome P450 Enzyme CYP1B1 by 4-Hydroxyemodin","volume":"171","author":"Lin","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"102588","DOI":"10.1016\/j.jbc.2022.102588","article-title":"Cell Adhesion Molecule CD44v10 Promotes Stem-like Properties in Triple-Negative Breast Cancer Cells via Glucose Transporter GLUT1-Mediated Glycolysis","volume":"298","author":"Guo","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB Pathway for the Therapy of Diseases: Mechanism and Clinical Study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","article-title":"NF-\u03baB in Cancer: From Innocent Bystander to Major Culprit","volume":"2","author":"Karin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1158\/2159-8290.CD-11-0260","article-title":"NF-\u03baB in Cancer: A Matter of Life and Death","volume":"1","author":"Aggarwal","year":"2011","journal-title":"Cancer Discov."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2313671","DOI":"10.1080\/07853890.2024.2313671","article-title":"MUC1-EGFR Crosstalk with IL-6 by Activating NF-\u03baB and MAPK Pathways to Regulate the Stemness and Paclitaxel-Resistance of Lung Adenocarcinoma","volume":"56","author":"Xu","year":"2024","journal-title":"Ann. Med."},{"key":"ref_95","first-page":"50","article-title":"Paclitaxel Resistance Is Mediated by NF-\u03baB on Mesenchymal Primary Breast Cancer Cells","volume":"23","author":"Longoria","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"564","DOI":"10.21147\/j.issn.1000-9604.2020.05.02","article-title":"Tim-3 Promotes Cell Aggressiveness and Paclitaxel Resistance through NF-\u03baB\/STAT3 Signalling Pathway in Breast Cancer Cells","volume":"32","author":"Cong","year":"2020","journal-title":"Chin. J. Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12964-020-00600-2","article-title":"Kinase shRNA Screening Reveals That TAOK3 Enhances Microtubule-Targeted Drug Resistance of Breast Cancer Cells via the NF-\u03baB Signaling Pathway","volume":"18","author":"Lai","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Tan, X.-Q., Guo, A.-Y., Zheng, L.-F., and Xiong, J. (2025). Research Progress on FOXM1 in Ovarian Cancer Diagnosis and Therapeutics. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1598868"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-407190-2.00016-2","article-title":"FOXM1 (Forkhead Box M1) in Tumorigenesis: Overexpression in Human Cancer, Implication in Tumorigenesis, Oncogenic Functions, Tumor-Suppressive Properties, and Target of Anticancer Therapy","volume":"Volume 119","author":"Wierstra","year":"2013","journal-title":"Advances in Cancer Research"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Li, M., Sun, T., Zhang, Z., and Liu, C. (2023). FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases. Biomolecules, 13.","DOI":"10.3390\/biom13050857"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"eabm5755","DOI":"10.1126\/scitranslmed.abm5755","article-title":"Endothelial FoxM1 Reactivates Aging-Impaired Endothelial Regeneration for Vascular Repair and Resolution of Inflammatory Lung Injury","volume":"15","author":"Huang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"208","DOI":"10.24976\/Discov.Med.202335176.22","article-title":"FOXM1 Contributes to Chemotherapy Sensitivity in Cervical Cancer by Regulating TTK","volume":"35","author":"Tang","year":"2023","journal-title":"Discov. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.freeradbiomed.2021.11.024","article-title":"FOXM1-Mediated Activation of Phospholipase D1 Promotes Lipid Droplet Accumulation and Reduces ROS to Support Paclitaxel Resistance in Metastatic Cancer Cells","volume":"179","author":"Zhang","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"155595","DOI":"10.1016\/j.cyto.2021.155595","article-title":"Acylglycerol Kinase Promotes Paclitaxel Resistance in Nasopharyngeal Carcinoma Cells by Regulating FOXM1 via the JAK2\/STAT3 Pathway","volume":"148","author":"Zhao","year":"2021","journal-title":"Cytokine"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3032590","DOI":"10.1155\/2022\/3032590","article-title":"FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription","volume":"2022","author":"Hou","year":"2022","journal-title":"BioMed Res. Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/bjc.2012.450","article-title":"Paclitaxel and CYC3, an Aurora Kinase a Inhibitor, Synergise in Pancreatic Cancer Cells but Not Bone Marrow Precursor Cells","volume":"107","author":"Lin","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1158\/1078-0432.CCR-07-2179","article-title":"Aurora Kinases as Anticancer Drug Targets","volume":"14","author":"Gautschi","year":"2008","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1535-6108(02)00235-0","article-title":"AURORA-a Amplification Overrides the Mitotic Spindle Assembly Checkpoint, Inducing Resistance to Taxol","volume":"3","author":"Anand","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_109","first-page":"739","article-title":"Function of Aurora Kinase a in Taxol-Resistant Breast Cancer and Its Correlation with P-Gp","volume":"4","author":"Li","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1038\/s41598-025-87315-x","article-title":"Proteomic Profiling Identifies Upregulation of Aurora Kinases Causing Resistance to Taxane-Type Chemotherapy in Triple Negative Breast Cancer","volume":"15","author":"Ning","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 Protein Family: Opposing Activities That Mediate Cell Death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ijc.32559","article-title":"Boosting the Apoptotic Response of High-Grade Serous Ovarian Cancers with CCNE1 Amplification to Paclitaxel in Vitro by Targeting APC\/C and the pro-Survival Protein MCL-1","volume":"146","author":"Raab","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bbrc.2020.02.133","article-title":"Low DEDD Expression in Breast Cancer Cells Indicates Higher Sensitivity to the Bcl-2-Specific Inhibitor ABT-199","volume":"525","author":"Liu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"116040","DOI":"10.1016\/j.bcp.2024.116040","article-title":"WP1066, a Small Molecule Inhibitor of STAT3, Chemosensitizes Paclitaxel-Resistant Ovarian Cancer Cells to Paclitaxel by Simultaneously Inhibiting the Activity of STAT3 and the Interaction of STAT3 with Stathmin","volume":"221","author":"Yang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"117437","DOI":"10.1016\/j.bcp.2025.117437","article-title":"FKBP38 Expression Level Dictates Paclitaxel Resistance via Interacting with Bcl-2 in Endometrial Cancer","volume":"243","author":"Yan","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.biopha.2017.04.043","article-title":"Targeting the Bcl-2 Family and P-Glycoprotein Reverses Paclitaxel Resistance in Human Esophageal Carcinoma Cell Line","volume":"90","author":"Shi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"75","DOI":"10.32604\/biocell.2022.016346","article-title":"An Active RUNX1-ID1\/ID3 Axis Governs Differentiation and Chemoresistance of Cancer Stem Cell Population in Epithelial Ovarian Cancer Cells","volume":"46","author":"Dhadve","year":"2021","journal-title":"Biocell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/bs.vh.2023.06.005","article-title":"The Human Glucocorticoid Receptor","volume":"123","author":"Nicolaides","year":"2023","journal-title":"Vitam. Horm."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Wang, W., Li, Z., Zhao, J., Chang, M., Zhang, Y., Shen, X., Yue, J., Schorge, J., and Zhang, W. (2026). Targeting Glucocorticoid Receptor Signaling in Platinum-Resistant Ovarian Cancer: Translational Rationale and Clinical Advances Following the ROSELLA Trial. Oncol. Rev., 20.","DOI":"10.3389\/or.2026.1861081"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Buonaiuto, R., Neola, G., Cecere, S.C., Caltavituro, A., Cefaliello, A., Pietroluongo, E., De Placido, P., Giuliano, M., Arpino, G., and De Angelis, C. (2023). Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention. Biomolecules, 13.","DOI":"10.3390\/biom13040653"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1530\/ERC-20-0489","article-title":"Duality of Glucocorticoid Action in Cancer: Tumor-Suppressor or Oncogene?","volume":"28","author":"Zwart","year":"2021","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4161\/cbt.6.2.3652","article-title":"Clinical and Mechanistic Aspects of Glucocorticoid-Induced Chemotherapy Resistance in the Majority of Solid Tumors","volume":"6","author":"Zhang","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"ref_123","first-page":"551","article-title":"Glucocorticoid-Mediated Inhibition of Chemotherapy in Ovarian Carcinomas","volume":"28","author":"Zhang","year":"2006","journal-title":"Int. J. Oncol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.18632\/oncotarget.27989","article-title":"Glucocorticoid Receptor Antagonism Promotes Apoptosis in Solid Tumor Cells","volume":"12","author":"Greenstein","year":"2021","journal-title":"Oncotarget"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.apsb.2025.04.001","article-title":"Psychological Stress-Activated NR3C1\/NUPR1 Axis Promotes Ovarian Tumor Metastasis","volume":"15","author":"Liu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Rivera-L\u00f3pez, Y.A., Torres-Rosado, A.P., Casiano-Mart\u00ednez, J.A., Mel\u00e9ndez-Rodr\u00edguez, L.L., Imad-Hamad, R., Hern\u00e1ndez-Carrasquillo, S.M., Rivera-P\u00e9rez, L.M., Ortiz-Le\u00f3n, M., Torres-Rodr\u00edguez, O.I., and Aquino-Acevedo, A.N. (2025). Chronic Stress Drives Ovarian Cancer Progression via Myeloid-Derived Suppressor Cells Infiltration and Notch Signaling Pathway Activation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1593299"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Schweer, D., McAtee, A., Neupane, K., Richards, C., Ueland, F., and Kolesar, J. (2022). Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy. Cancers, 14.","DOI":"10.3390\/cancers14092220"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.2147\/OTT.S216355","article-title":"Tumor-Associated Macrophages (TAMs): A Critical Activator in Ovarian Cancer Metastasis","volume":"12","author":"Yin","year":"2019","journal-title":"Onco Targets Ther."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Ho, C.J., and Gorski, S.M. (2019). Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer. Cancers, 11.","DOI":"10.3390\/cancers11111775"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/s41467-018-04070-6","article-title":"Autophagy Promotes the Survival of Dormant Breast Cancer Cells and Metastatic Tumour Recurrence","volume":"9","author":"Vodnala","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/cdd.2013.103","article-title":"Autophagy and Genomic Integrity","volume":"20","author":"Vessoni","year":"2013","journal-title":"Cell Death Differ."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Eliopoulos, A.G., Havaki, S., and Gorgoulis, V.G. (2016). DNA Damage Response and Autophagy: A Meaningful Partnership. Front. Genet., 7.","DOI":"10.3389\/fgene.2016.00204"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.287524.116","article-title":"Recent Insights into the Function of Autophagy in Cancer","volume":"30","author":"Amaravadi","year":"2016","journal-title":"Genes. Dev."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-cancerbio-041816-122338","article-title":"The Role of Autophagy in Cancer","volume":"1","author":"Mancias","year":"2017","journal-title":"Annu. Rev. Cancer Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e108863","DOI":"10.15252\/embj.2021108863","article-title":"Autophagy in Major Human Diseases","volume":"40","author":"Klionsky","year":"2021","journal-title":"EMBO J."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12967-022-03462-z","article-title":"Inhibition of Autophagy by Chloroquine Prevents Resistance to PI3K\/AKT Inhibitors and Potentiates Their Antitumor Effect in Combination with Paclitaxel in Triple Negative Breast Cancer Models","volume":"20","author":"Cocco","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.apsb.2019.03.006","article-title":"Actively Priming Autophagic Cell Death with Novel Transferrin Receptor-Targeted Nanomedicine for Synergistic Chemotherapy against Breast Cancer","volume":"9","author":"Mei","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","article-title":"Metabolism of Pancreatic Cancer: Paving the Way to Better Anticancer Strategies","volume":"19","author":"Qin","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Dong, P., Wang, F., Taheri, M., Xiong, Y., Ihira, K., Kobayashi, N., Konno, Y., Yue, J., and Watari, H. (2022). Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting with miR-140 and miR-143. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.912935"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"216338","DOI":"10.1016\/j.canlet.2023.216338","article-title":"The CAIX Inhibitor SLC-0111 Exerts Anti-Cancer Activity on Gastric Cancer Cell Lines and Resensitizes Resistant Cells to 5-Fluorouracil, Taxane-Derived, and Platinum-Based Drugs","volume":"571","author":"Andreucci","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The Role of Carbonic Anhydrase IX in Cancer Development: Links to Hypoxia, Acidosis, and Beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jclinpath-2020-207073","article-title":"Carbonic Anhydrase IX: A Regulator of pH and Participant in Carcinogenesis","volume":"74","author":"Aldera","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jare.2024.12.003","article-title":"Cancer-Associated Fibroblasts Regulate Mitochondrial Metabolism and Inhibit Chemosensitivity via ANGPTL4-IQGAP1 Axis in Prostate Cancer","volume":"75","author":"Xiong","year":"2025","journal-title":"J. Adv. Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2147\/OTT.S233031","article-title":"Knockdown of FOXO6 Inhibits Glycolysis and Reduces Cell Resistance to Paclitaxel in HCC Cells via PI3K\/Akt Signaling Pathway","volume":"13","author":"Yu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","article-title":"Noncoding RNAs in Gastric Cancer: Implications for Drug Resistance","volume":"19","author":"Wei","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2207257","DOI":"10.1002\/advs.202207257","article-title":"Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy","volume":"10","author":"Jiang","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000519844","article-title":"LncRNA HOTAIR Promotes Chemoresistance by Facilitating Epithelial to Mesenchymal Transition through miR-29b\/PTEN\/PI3K Signaling in Cervical Cancer","volume":"211","author":"Zhang","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2147\/OTT.S240434","article-title":"Long Noncoding RNA TUG1 Promotes Autophagy-Associated Paclitaxel Resistance by Sponging miR-29b-3p in Ovarian Cancer Cells","volume":"13","author":"Gu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Tang, L., Chen, Y., Chen, H., Jiang, P., Yan, L., Mo, D., Tang, X., and Yan, F. (2020). DCST1-AS1 Promotes TGF-\u03b2-Induced Epithelial-Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00280"},{"key":"ref_150","first-page":"9516774","article-title":"lncRNA-DANCR Promotes Taxol Resistance of Prostate Cancer Cells through Modulating the miR-33b-5p-LDHA Axis","volume":"2022","author":"Wang","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/1120009X.2022.2157618","article-title":"LncRNA-SNHG1 Promotes Paclitaxel Resistance of Gastric Cancer Cells through Modulating the miR-216b-5p-Hexokianse 2 Axis","volume":"35","author":"Xu","year":"2023","journal-title":"J. Chemother."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13402-017-0341-9","article-title":"A Step-by-Step microRNA Guide to Cancer Development and Metastasis","volume":"40","author":"Markopoulos","year":"2017","journal-title":"Cell. Oncol."},{"key":"ref_153","first-page":"83","article-title":"MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions","volume":"3","author":"Shukla","year":"2011","journal-title":"Mol. Cell. Pharm."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12013-014-0450-2","article-title":"Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel","volume":"72","author":"Jin","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"ref_155","first-page":"326","article-title":"Paclitaxel-Resistant Gastric Cancer MGC-803 Cells Promote Epithelial-to-Mesenchymal Transition and Chemoresistance in Paclitaxel-Sensitive Cells via Exosomal Delivery of miR-155-5p","volume":"54","author":"Wang","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/1759-7714.13475","article-title":"Circ-RNF111 Contributes to Paclitaxel Resistance in Breast Cancer by Elevating E2F3 Expression via miR-140-5p","volume":"11","author":"Zang","year":"2020","journal-title":"Thorac. Cancer"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/15384047.2020.1727700","article-title":"Knockdown of lncRNA CCAT1 Enhances Sensitivity of Paclitaxel in Prostate Cancer via Regulating miR-24-3p and FSCN1","volume":"21","author":"Li","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1080\/15476286.2020.1851540","article-title":"Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomal microRNA-451a Represses Epithelial\u2013Mesenchymal Transition of Hepatocellular Carcinoma Cells by Inhibiting ADAM10","volume":"18","author":"Xu","year":"2021","journal-title":"RNA Biol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"153405","DOI":"10.1016\/j.prp.2021.153405","article-title":"MicroRNA-155-5p Promotes Tumor Progression and Contributes to Paclitaxel Resistance via TP53INP1 in Human Breast Cancer","volume":"220","author":"Li","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"ref_160","first-page":"802","article-title":"CircEXOC6B Suppresses the Proliferation and Motility and Sensitizes Ovarian Cancer Cells to Paclitaxel through miR-376c-3p\/FOXO3 Axis","volume":"37","author":"Zheng","year":"2022","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12943-020-01231-4","article-title":"CircRNAs: Biogenesis, Functions, and Role in Drug-Resistant Tumours","volume":"19","author":"Ma","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.omtn.2019.12.005","article-title":"circCELSR1 (Hsa-Circ-0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.omtn.2020.06.002","article-title":"Circular RNA circTNPO3 Regulates Paclitaxel Resistance of Ovarian Cancer Cells by miR-1299\/NEK2 Signaling Pathway","volume":"21","author":"Xia","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"9497","DOI":"10.2147\/OTT.S252886","article-title":"Circ_0006528 Contributes to Paclitaxel Resistance of Breast Cancer Cells by Regulating miR-1299\/CDK8 Axis","volume":"13","author":"Liu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"24171","DOI":"10.18632\/aging.203672","article-title":"LncRNA OTUD6B-AS1 Promotes Paclitaxel Resistance in Triple Negative Breast Cancer by Regulation of miR-26a-5p\/MTDH Pathway-Mediated Autophagy and Genomic Instability","volume":"13","author":"Li","year":"2021","journal-title":"Aging"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13058-022-01537-9","article-title":"DNA Methylation Changes in Response to Neoadjuvant Chemotherapy Are Associated with Breast Cancer Survival","volume":"24","author":"Pedersen","year":"2022","journal-title":"Breast Cancer Res."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Shi, Y., Gong, W., Gong, X., Wang, P., and Zhao, X. (2020). Genome-Wide DNA Methylation Analysis of Breast Cancer MCF-7\/Taxol Cells with MeDIP-Seq. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241515"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Xiang, F., Zhu, Z., Zhang, M., Wang, J., Chen, Z., Li, X., Zhang, T., Gu, Q., Wu, R., and Kang, X. (2021). 3,3\u2019-Diindolylmethane Enhances Paclitaxel Sensitivity by Suppressing DNMT1-Mediated KLF4 Methylation in Breast Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.627856"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"23369","DOI":"10.1002\/jcla.23369","article-title":"Hypermethylation of lncRNA MEG3 Impairs Chemosensitivity of Breast Cancer Cells","volume":"34","author":"Li","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Bouyahya, A., Mechchate, H., Oumeslakht, L., Zeouk, I., Aboulaghras, S., Balahbib, A., Zengin, G., Kamal, M.A., Gallo, M., and Montesano, D. (2022). The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. Biomolecules, 12.","DOI":"10.3390\/biom12030367"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Li, W., Wu, H., Sui, S., Wang, Q., Xu, S., and Pang, D. (2021). Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.736935"},{"key":"ref_172","first-page":"174","article-title":"Super-Enhancers: A New Frontier for Epigenetic Modifiers in Cancer Chemoresistance","volume":"40","author":"Li","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"30566","DOI":"10.1073\/pnas.2009506117","article-title":"Aneuploidy Increases Resistance to Chemotherapeutics by Antagonizing Cell Division","volume":"117","author":"Replogle","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1158\/0008-5472.CAN-19-0852","article-title":"Specific Mechanisms of Chromosomal Instability Indicate Therapeutic Sensitivities in High-Grade Serous Ovarian Carcinoma","volume":"80","author":"Tamura","year":"2020","journal-title":"Cancer Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tips.2024.01.009","article-title":"Targeting Chromosomal Instability and Aneuploidy in Cancer","volume":"45","author":"Bhatia","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.devcel.2021.07.009","article-title":"Chromosomal Instability Accelerates the Evolution of Resistance to Anti-Cancer Therapies","volume":"56","author":"Lukow","year":"2021","journal-title":"Dev. Cell"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/0008-5472.CAN-23-3332","article-title":"CENP-E Inhibition Induces Chromosomal Instability and Synergizes with Diverse Microtubule-Targeting Agents in Breast Cancer","volume":"84","author":"Tucker","year":"2024","journal-title":"Cancer Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.7150\/thno.103636","article-title":"Tumor Microenvironment Targeted Nano-Drug Delivery Systems for Multidrug Resistant Tumor Therapy","volume":"15","author":"Shao","year":"2025","journal-title":"Theranostics"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic Targeting of the Tumor Microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The Updated Landscape of Tumor Microenvironment and Drug Repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","article-title":"Advances in Immunotherapy for Triple-Negative Breast Cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Tian, T., Han, J., Huang, J., Li, S., and Pang, H. (2021). Hypoxia-Induced Intracellular and Extracellular Heat Shock Protein Gp96 Increases Paclitaxel-Resistance and Facilitates Immune Evasion in Breast Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.784777"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00109-021-02138-3","article-title":"JAK2 Regulates Paclitaxel Resistance in Triple Negative Breast Cancers","volume":"99","author":"Han","year":"2021","journal-title":"J. Mol. Med.-JMM"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"113474","DOI":"10.1016\/j.biopha.2022.113474","article-title":"CCL2 Overexpression Is Associated with Paclitaxel Resistance in Ovarian Cancer Cells via Autocrine Signaling and Macrophage Recruitment","volume":"153","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ajpath.2012.08.011","article-title":"Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205","volume":"181","author":"Puhr","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_186","first-page":"249","article-title":"Role of VOPP1 in Regulation of Paclitaxel Response and EMT Process during Ovarian Tumor Progression","volume":"14","author":"Khajavirad","year":"2025","journal-title":"Mol. Biol. Res. Commun."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s11033-026-12050-z","article-title":"Adapalene Inhibits the Activity of CD44, a Cancer Stem Cell Biomarker in Triple Negative Breast Cancer","volume":"53","author":"Sofi","year":"2026","journal-title":"Mol. Biol. Rep."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10495-026-02310-5","article-title":"Autophagy-Lysosomal Dependency Defines a Vulnerable Physiological State in Drug-Tolerant Persister Cells of Triple-Negative Breast Cancer","volume":"31","author":"Chatterjee","year":"2026","journal-title":"Apoptosis Int. J. Program. Cell Death"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.1999.17.6.1786","article-title":"Paclitaxel Resistance in Non-Small-Cell Lung Cancer Associated with Beta-Tubulin Gene Mutations","volume":"17","author":"Rosell","year":"1999","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1073\/pnas.0408974102","article-title":"Microtubule-Associated Protein Tau: A Marker of Paclitaxel Sensitivity in Breast Cancer","volume":"102","author":"Rouzier","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"16","DOI":"10.32604\/or.2025.068967","article-title":"Utilization of a UPLC-MS\/MS Approach to Elucidate the Role of ABCB1-Mediated Paclitaxel Resistance in Non-Small Cell Lung Cancer Cells","volume":"34","author":"Hu","year":"2026","journal-title":"Oncol. Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00432-024-05833-z","article-title":"New Uracil Analog as Inhibitor\/Modulator of ABC Transporters or\/and NF-\u03baB in Taxol-Resistant MCF-7\/Tx Cell Line","volume":"150","author":"Janecki","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_193","first-page":"37","article-title":"Regulation of Oncoprotein 18\/Stathmin Signaling by ERK Concerns the Resistance to Taxol in Nonsmall Cell Lung Cancer Cells","volume":"31","author":"Lin","year":"2016","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"118141","DOI":"10.1016\/j.ejmech.2025.118141","article-title":"Aurora a Degradation by HSP90 Interactome-Mediating PROTACs in A549 and Paclitaxel-Resistant A549 Cells","volume":"300","author":"Deng","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Wise, A.R., Maloney, S., Hering, A., Zabala, S., Richmond, G.E., VanKlompenberg, M.K., Nair, M.T., and Prosperi, J.R. (2024). Bcl-2 up-Regulation Mediates Taxane Resistance Downstream of APC Loss. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126745"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"120328","DOI":"10.1016\/j.lfs.2022.120328","article-title":"KHDRBS3 Promotes Paclitaxel Resistance and Induces Glycolysis through Modulated MIR17HG\/CLDN6 Signaling in Epithelial Ovarian Cancer","volume":"293","author":"Wu","year":"2022","journal-title":"Life Sci."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Singh, B., Sarli, V.N., and Lucci, A. (2022). Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor. Cancers, 14.","DOI":"10.20944\/preprints202204.0183.v1"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12032-025-03108-2","article-title":"Combination of SH003 and Paclitaxel Modulates Tumor Microenvironment and Inhibits Metastasis of Metastatic Melanoma","volume":"43","author":"Lee","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/era.12.158","article-title":"Class III B-Tubulin Overexpression in Gynecologic Tumors: Implications for the Choice of Microtubule Targeted Agents?","volume":"13","author":"English","year":"2013","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.2174\/138161212800626238","article-title":"Novel Drugs Targeting Microtubules: The Role of Epothilones","volume":"18","author":"Ferrandina","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clbc.2021.07.015","article-title":"Xiao-ai Lv Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer via Inhibiting PI3K\/Akt\/mTOR-Mediated Autophagy","volume":"22","author":"Zhang","year":"2022","journal-title":"Clin. Breast Cancer"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"115816","DOI":"10.1016\/j.taap.2021.115816","article-title":"A Natural Product, Voacamine, Sensitizes Paclitaxel-Resistant Human Ovarian Cancer Cells","volume":"434","author":"Pellegrini","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_203","first-page":"167","article-title":"PEITC by Regulating Aurora Kinase a Reverses Chemoresistance in Breast Cancer Cells","volume":"57","author":"Biswas","year":"2020","journal-title":"Indian J. Biochem. Biophys."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13046-022-02295-4","article-title":"HDAC Class I Inhibitor Domatinostat Sensitizes Pancreatic Cancer to Chemotherapy by Targeting Cancer Stem Cell Compartment via FOXM1 Modulation","volume":"41","author":"Roca","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Nakagawa-Saito, Y., Mitobe, Y., Suzuki, S., Togashi, K., Sugai, A., Kitanaka, C., and Okada, M. (2023). Domatinostat Targets the FOXM1\u2013Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310817"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"115408","DOI":"10.1016\/j.bcp.2022.115408","article-title":"Low Bcl-2 Is a Robust Biomarker of Sensitivity to Nab-Paclitaxel in Ewing Sarcoma","volume":"208","author":"Aschero","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12935-024-03607-8","article-title":"Proapoptotic Role of CDK1 in Overcoming Paclitaxel Resistance in Ovarian Cancer Cells in Response to Combined Treatment with Paclitaxel and Duloxetine","volume":"24","author":"Kim","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpb.2023.04.016","article-title":"Co-Delivery of Doxorubicin and Paclitaxel via Noisome Nanocarriers Attenuates Cancerous Phenotypes in Gastric Cancer Cells","volume":"188","author":"Rezaei","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-21-4363","article-title":"Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors","volume":"28","author":"Munster","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/S0140-6736(25)01040-2","article-title":"Relacorilant and Nab-Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer (ROSELLA): An Open-Label, Randomised, Controlled, Phase 3 Trial","volume":"405","author":"Olawaiye","year":"2025","journal-title":"Lancet"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s10495-019-01526-y","article-title":"Autophagy Inhibition with Chloroquine Reverts Paclitaxel Resistance and Attenuates Metastatic Potential in Human Nonsmall Lung Adenocarcinoma A549 Cells via ROS Mediated Modulation of \u03b2-Catenin Pathway","volume":"24","author":"Datta","year":"2019","journal-title":"Apoptosis"},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Hou, Z., Lin, S., Du, T., Wang, M., Wang, W., You, S., Xue, N., Liu, Y., Ji, M., and Xu, H. (2023). S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. Pharmaceuticals, 16, Correction in Pharmaceuticals 2025, 18, 1355.","DOI":"10.3390\/ph18091355"},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Raab, M., Rak, M., Tesch, R., Gasimli, K., Becker, S., Knapp, S., Strebhardt, K., and Sanhaji, M. (2021). The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer Cells. Cancers, 13.","DOI":"10.3390\/cancers13153658"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"117452","DOI":"10.1016\/j.biopha.2024.117452","article-title":"Paclitaxel-Resistance Facilitates Glycolytic Metabolism via Hexokinase-2-Regulated ABC and SLC Transporter Genes in Ovarian Clear Cell Carcinoma","volume":"180","author":"Lin","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"109702","DOI":"10.1016\/j.cbi.2021.109702","article-title":"FV-429 Enhances the Efficacy of Paclitaxel in NSCLC by Reprogramming HIF-1\u03b1-Modulated FattyAcid Metabolism","volume":"350","author":"Guo","year":"2021","journal-title":"Chem.-Biol. Interact."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(20)31953-X","article-title":"Neoadjuvant Atezolizumab in Combination with Sequential Nab-Paclitaxel and Anthracycline-Based Chemotherapy versus Placebo and Chemotherapy in Patients with Early-Stage Triple-Negative Breast Cancer (IMpassion031): A Randomised, Double-Blind, Phase 3 Trial","volume":"396","author":"Mittendorf","year":"2020","journal-title":"Lancet"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Chang, Y., Gao, X., Jiang, Y., Wang, J., Liu, L., Yan, J., Huang, G., and Yang, H. (2024). Alpha-Hederin Reprograms Multi-miRNAs Activity and Overcome Small Extracellular Vesicles-Mediated Paclitaxel Resistance in NSCLC. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1257941"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2022.09.007","article-title":"Paclitaxel-Loaded Ginsenoside Rg3 Liposomes for Drug-Resistant Cancer Therapy by Dual Targeting of the Tumor Microenvironment and Cancer Cells","volume":"49","author":"Zhu","year":"2023","journal-title":"J. Adv. Res."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Villegas, C., Gonz\u00e1lez-Chavarr\u00eda, I., Burgos, V., Iturra-Beiza, H., Ulrich, H., and Paz, C. (2023). Epothilones as Natural Compounds for Novel Anticancer Drugs Development. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076063"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1200\/JCO.2011.38.8082","article-title":"Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) with Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients with Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer","volume":"30","author":"Colombo","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_221","first-page":"1221","article-title":"A Phase I Trial of Doxorubicin, Paclitaxel, and Valspodar (PSC 833), a Modulator of Multidrug Resistance","volume":"7","author":"Advani","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1200\/JCO.2007.14.9807","article-title":"Phase III Study of Valspodar (PSC 833) Combined with Paclitaxel and Carboplatin Compared with Paclitaxel and Carboplatin Alone in Patients with Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer","volume":"26","author":"Joly","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.annonc.2021.01.065","article-title":"A Phase II Randomized Trial of Cobimetinib plus Chemotherapy, with or without Atezolizumab, as First-Line Treatment for Patients with Locally Advanced or Metastatic Triple-Negative Breast Cancer (COLET): Primary Analysis","volume":"32","author":"Brufsky","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(26)00462-9","article-title":"Overall Survival with Relacorilant and Nab-Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer (ROSELLA): A Phase 3 Randomised Controlled Trial","volume":"407","author":"Lorusso","year":"2026","journal-title":"Lancet"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7187\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:58:49Z","timestamp":1786521529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":224,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167187"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167187","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}